SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Centocor ( CNTO )
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
965 13 0 CNTO
Emcee:  PawPr Type:  Unmoderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
15 Does anyone knows when Eli Lilly next quarterly report will come out. It shoulThean-10/15/1996
14 I agree with your interpretation of the data. As I said in my earlier posting, PawPr-8/2/1996
13 CNTO Q2 earning out today: -0.06 vs consensus estimate of -0.08. Reopro sales Thean-8/1/1996
12 Results announced today- quite impressive. It looks like the recent run-up in tPawPr-5/22/1996
11 Has anyone attended the Digestive Disease conference at SF? Were there any newThean-5/22/1996
10 Bruce: What a Journal! The thing must weigh at least 10 pounds. After siftTevyah-5/20/1996
9 thanks Bruce. I must say I thought Centocor were releasing the results of the sClive Roberts-5/19/1996
8 As the person who started the posting on Centocor and an ( associate ) editor PawPr-5/18/1996
7 They are announcing at a Conference on may 22. No news yet.Clive Roberts-5/14/1996
6 Regarding rheumatoid arthritis, the writer of the email gives us an anecdote wiClive Roberts-5/14/1996
5 Thean Below I attach the text of a letter found way back within alt.support.cClive Roberts-5/14/1996
4 I have not seen their ca2 result. Is ca2 the code for the Crohns disease cliniThean-5/13/1996
3 Their Phase 11 ca2 results are announced at Digestive Diseases Week on May 22. Clive Roberts-5/12/1996
2 Being first-to-market in a new therapeutic category usually allows a company toThean-5/6/1996
1 The rate limiting factor will be the cost. Currently only used for high risk aolduser-5/5/1996
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News